Rochester Medical Corporation (ROCM)

NASDAQ

Currency in USD

20.00

0.00(0.00%)

Closed·13/11

Day's Range

19.98

20.00

52 wk Range

0.00

20.00

ROCM Income Statement

Featured here, the Income Statement (earnings report) for Rochester Medical Corporation, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2003

30/09

2004

30/09

2005

30/09

2006

30/09

2007

30/09

2008

30/09

2009

30/09

2010

30/09

2011

30/09

2012

30/09

Total Revenues

aa.aa

35.19

34.8

41.55

53.37

61.68

Total Revenues Growth

aa.aa

+7.74%

-1.12%

+19.39%

+28.46%

+15.57%

Cost Of Revenues

aa.aa

18.48

17.97

21.51

26.72

30.87

Gross Profit

aa.aa

16.71

16.83

20.04

26.65

30.82

Gross Profit Growth

aa.aa

-1.97%

+0.7%

+19.1%

+32.99%

+15.64%

Gross Profit Margin %

aa.aa

47.48%

48.35%

48.23%

49.93%

49.96%

Other Operating Expenses, Total

aa.aa

17.2

17.58

19.83

28.33

27.6

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+21.33%	+2.18%	+12.83%	+42.84%	-2.55%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.04	1.24	1.24	1.01	1.19
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	16.16	16.33	18.59	27.32	26.41
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-0.49

-0.75

0.21

-1.68

3.21

Operating Income Growth

aa.aa

-117.19%

-52.16%

+127.81%

-904.29%

+291.55%

EBIT Margin %

aa.aa

-1.4%

-2.15%

0.5%

-3.14%

5.21%

Net Interest Expenses

aa.aa

0.76

0.02

0.06

-0.14

-0.05

Net Interest Expenses Growth

aa.aa

-1.7%

-96.87%

+158.95%

-322.03%

+66.24%

Interest Expense, Total

aa.aa

-0.48

-0.26

-0.18

-0.28

-0.09

Interest And Investment Income

aa.aa

1.24

0.28

0.24

0.14

0.04

Other Non Operating Expenses, Total

aa.aa

-0.09

0.2

-0.12

0.04

EBT, Excl. Unusual Items

aa.aa

0.18

-0.53

0.27

-1.94

3.21

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

0.18

0.47

0.27

-1.94

3.08

EBT, Incl. Unusual Items Growth

aa.aa

-99.57%

+162.62%

-43.02%

-817.08%

+259.01%

EBT, Incl. Unusual Items Margin

aa.aa

0.51%

1.36%

0.65%

-3.63%

Income Tax Expense

aa.aa

-0.58

0.37

0.52

-0.62

1.03

Net Income to Company

aa.aa

0.76

0.11

-0.25

-1.32

2.05

Minority Interest

aa.aa

Net Income

aa.aa

0.76

0.11

-0.25

-1.32

2.05

Net Income Growth

aa.aa

-97.77%

-85.68%

-333.3%

-418.79%

+255.89%

Net Income Margin %

aa.aa

2.16%

0.31%

-0.61%

-2.46%

3.32%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

0.76

0.11

-0.25

-1.32

2.05

Basic EPS - Continuing Operations

aa.aa

0.06

0.01

-0.02

-0.11

0.17

Basic EPS - Continuing Operations Growth

aa.aa

-97.84%

-85.96%

-330.72%

-417.24%

+258.3%

Diluted EPS - Continuing Operations

aa.aa

0.06

0.01

-0.02

-0.11

0.17

Diluted EPS - Continuing Operations Growth

aa.aa

-97.83%

-84.96%

-330.72%

-428.52%

+254.55%

Basic Weighted Average Shares Outstanding

aa.aa

11.82

12.05

12.18

12.22

12.03

Diluted Weighted Average Shares Outstanding

aa.aa

12.58

12.64

12.18

12.22

12.34

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

1.43

1.18

2.31

0.84

5.86

EBITDA Growth

aa.aa

-69.83%

-17.91%

+96.39%

-63.67%

+598.27%

EBITDA Margin %

aa.aa

4.07%

3.38%

5.56%

1.57%

9.5%

EBIT

aa.aa

-0.49

-0.75

0.21

-1.68

3.21

* In Millions of USD (except for per share items)

NSE 30

5,442.77

+25.83

+0.48%

NSE All Share

149,035.10

+680.06

+0.46%

US 30

45,946.30

-5.9

-0.01%

US 500

6,616.50

-12.6

-0.19%

FTSE 100

9,339.40

-96.69

-1.02%

DAX

23,902.70

-370.23

-1.53%

South Africa Top 40

104,244.80

-1,511.22

-1.43%

Market Movers

Name	Last	Chg. %	Vol.
UBA	42.15	+0.36%	48.14M
Fidelitybk	20.000	-0.50%	45.94M
Access Holdings	25.80	0.00%	39.20M
Wema Bank	18.80	0.00%	15.65M
Vitafoam Nig	84.00	-0.59%	6.51M
Dangote Cement	605.00	+0.87%	2.13M
Nestle Nigeria	1,980.00	+3.39%	146.95K

Name	Last	Chg. %	Vol.
Eunisell Interlinked	48.400	+10.00%	552.33K
Airtel Africa	2,541.50	+10.00%	832.00
Mutual Benefits Assurance	4.17	+9.16%	5.94M
Tripple Gee and Co	5.35	+8.96%	91.67K
Sovereign Trust Insurance Plc	3.58	+9.82%	28.76M
SCOA Nigeria	7.090	+7.59%	10.61K
Skye Shelter Fund	448.00	+6.99%	4.35K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	31.86K
Total Nig	576.00	-10.00%	6.09K
Livingtrust Mortgage Bank	4.50	-10.00%	15.00K
Betaglas	437.40	-10.00%	14.44K
Juli	8.06	-9.94%	4.20K
Transcorp Power	307.80	-10.00%	38.42K
Multverse	12.65	-8.99%	24.96K

Trending Stocks

Name	Last	Chg. %	Vol.
Dangote Cement	606.00	+1.03%	2.09M
Lafarge Africa	135.50	+1.88%	1.28M
Guaranty Trust Holding	93.35	-0.16%	2.83M
Aradel Holdings	647.10	+2.55%	342.30K
MTN Nigeria	474.20	+0.62%	443.99K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaa Aaaaaa	5,917.20	+46.82%	8,687.63
Aaaa A Aaa	1,980.00	+36.25%	2,697.75
Aaaaaaaa A A Aa	605.00	+26.57%	765.75
Aaaa Aaaaaaaaaa	39.10	+24.39%	48.64
Aaa Aaaa Aaaa Aa	68.55	+21.29%	83.14
Aa A Aaaaaa Aaaaaaaa	159.90	+18.96%	190.22
Aaaaaaa	576.00	+14.14%	657.45

Name	Last	Upside	Fair Value
Aa Aaaa Aaaaaa	5,917.20	+46.82%	8,687.63
Aaaa A Aaa	1,980.00	+36.25%	2,697.75
Aaaaaaaa A A Aa	605.00	+26.57%	765.75
Aaaa Aaaaaaaaaa	39.10	+24.39%	48.64
Aaa Aaaa Aaaa Aa	68.55	+21.29%	83.14
Aa A Aaaaaa Aaaaaaaa	159.90	+18.96%	190.22
Aaaaaaa	576.00	+14.14%	657.45

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Rochester Medical Corporation (ROCM)

ROCM Income Statement

Trending Stocks